Food Effect Study on the Pharmacokinetics of VC004 Capsules in Healthy Adult Subjects
- Conditions
- Interventions
- First Posted Date
- 2022-09-06
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 16
- Registration Number
- NCT05528120
- Locations
- π¨π³
Zhongda Hospital,Affiliated to Southeast University, Nanjing, Jiangsu, China
Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2022-04-29
- Last Posted Date
- 2022-11-17
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 60
- Registration Number
- NCT05354752
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
PK/PD Study of Vicagrel and Clopidogrel in Healthy Subjects With Different CYP2C19 Metabolizers
- Conditions
- Interventions
- First Posted Date
- 2021-12-17
- Last Posted Date
- 2023-11-03
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 128
- Registration Number
- NCT05162053
- Locations
- πΊπΈ
Altasciences, Kansas City, Kansas City, Missouri, United States
πΊπΈAltasciences Clinical, Los Angeles, Los Angeles, California, United States
π¨π³Phase I Clinical Research Center of The First Hospital of Jilin University, Changchun, Jilin, China
Pharmacokinetics and Pharmacodynamics Clinical Study of VC005 Tablets in Healthy Subjects
- Conditions
- Interventions
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2022-09-02
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 78
- Registration Number
- NCT05138770
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
A Clinical Trial to Evaluate the Effect of Food on PK and PD of Vicagrel Capsules in Healthy Adult Subjects
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2021-11-01
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 24
- Registration Number
- NCT04919551
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
The Phase I/Phase II Clinical Study of VC004 in Patients With Localized Advanced/Metastatic Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2020-11-04
- Last Posted Date
- 2022-12-13
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 115
- Registration Number
- NCT04614740
- Locations
- π¨π³
Anhui Provincial Cancer Hospital, Hefei, Anhui, China
π¨π³Hainan Cancer Hospital, Haikou, Hainan, China
π¨π³Hubei Cancer Hospital, Wuhan, China
The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man
- First Posted Date
- 2019-10-29
- Last Posted Date
- 2020-04-03
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 6
- Registration Number
- NCT04143750
- Locations
- π¨π³
The First Affiliated Hospital of Suzhou University, Suzhou, Jiangsu, China
Pharmacokinetics and Pharmacodynamics of Vicagrel in Healthy Adult Subjects of Different CYP2C19
- Conditions
- Interventions
- First Posted Date
- 2019-05-08
- Last Posted Date
- 2019-09-19
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 50
- Registration Number
- NCT03942458
- Locations
- π¨π³
The First Hospital of Jilin University, Chang chun, Jilin, China
The Efficacy, Safety and Pharmacokinetic of Antiplatelet Therapy for Vicagrel
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2019-09-23
- Lead Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD
- Target Recruit Count
- 279
- Registration Number
- NCT03599284
- Locations
- π¨π³
Second Xiangya Hospital of Central South University, Changsha, Hunan, China
π¨π³Qinghai Provincial People's Hospital, Xining, Qinghai, China
π¨π³Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, China